Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

NCT00606099 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study was cancelled

Conditions

Chronic Hepatitis B

Interventions

DRUG: telbivudine
DRUG: adefovir dipivoxil

Sponsor

Novartis